Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 25 Oct 24 424B3 Prospectus supplement
- 23 Sep 24 424B5 Prospectus supplement for primary offering
- 20 Sep 24 424B5 Prospectus supplement for primary offering
- 2 Aug 24 424B5 Prospectus supplement for primary offering
- 31 May 24 424B5 Prospectus supplement for primary offering
- 31 May 24 EFFECT Notice of effectiveness
- 29 May 24 S-3/A Shelf registration (amended)
-
17 May 24 S-3 Shelf registration
FBIO similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated March 28, 2024, with respect to the consolidated financial statements of Fortress Biotech, Inc., incorporated herein by reference, and to the reference to our firm under the heading "Experts" in the prospectus.
/s/ KPMG LLP
Short Hills, New Jersey
May 17, 2024